Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Kim, Sam Moon ^a   Song, Juhee ^a   Kim, Seungwoo ^a   Han, Changsu ^b   Park, Moon H ^b   Koh, Youngho ^a   Jo, Sangmee A ^a   Kim, Young Youl ^a  

^a Korea National Institute of Health   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Alzheimer's; biomarker; IL 8

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; HOMOCYSTEINE; INTERLEUKIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; CYCLOOXYGENASE 2; CYTOKINE; PTGS2 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; EDUCATIONAL STATUS; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; ANALYSIS OF VARIANCE; BLOOD; COGNITIVE DEFECT; INFLAMMATION; PSYCHOLOGICAL RATING SCALE; RANDOMIZATION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; COGNITION DISORDERS; CYCLOOXYGENASE 2; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; PSYCHIATRIC STATUS RATING SCALES; RANDOM ALLOCATION; RETROSPECTIVE STUDIES;

EID: 79955781066     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-51     Document Type: Article

References (38)

1. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004, 5(6):575-581. 10.1038/ni1078, 15164017.
2. Bermejo PE, Martín-Aragón S, Benedí J, Susín C, Felici E, Gil P, Ribera JM, Villar AM. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. Immunol Lett 2008, 117(2):198-202. 10.1016/j.imlet.2008.02.002, 18367253.
3. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7(1):75-83. 10.1002/glia.440070113, 8423065.
4. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989, 86(19):7611-7615. 10.1073/pnas.86.19.7611, 298116, 2529544.
5. Walker DG, Kim SU, McGeer PL. Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J Neurosci Res 1995, 40(4):478-493. 10.1002/jnr.490400407, 7616608.
6. Yamabe T, Dhir G, Cowan EP, Wolf AL, Bergey GK, Krumholz A, Barry E, Hoffman PM, Dhib-Jalbut S. Cytokine-gene expression in measles-infected adult human glial cells. J Neuroimmunol 1994, 49(1-2):171-179. 10.1016/0165-5728(94)90193-7, 8294554.
7. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21(3):383-421. 10.1016/S0197-4580(00)00124-X, 10858586.
8. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ. Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003, 289:2819-2826. 10.1001/jama.289.21.2819, 12783912.
9. Singh VK, Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatr Res 1997, 31(6):657-660. 10.1016/S0022-3956(97)00023-X, 9447570.
10. Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, Buchkremer G, Bartels M, Schott K. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease?. J Psychiatr Res 2005, 39(5):535-543. 10.1016/j.jpsychires.2004.12.005, 15992563.
11. van Duijn CM, Hofman A, Nagelkerken L. Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease. Neurosci Lett 1990, 108(3):350-354. 10.1016/0304-3940(90)90666-W, 2304653.
12. Shaw LM, Korecka M, Clark CM, Lee VM, Trojanowski JQ. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov 2007, 6(4):295-303. 10.1038/nrd2176, 17347655.
13. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007, 13(11):1359-1362. 10.1038/nm1653, 17934472.
14. Kinoshita J, Clark T. Alzforum. Methods Mol Biol 2007, 401:365-381. 10.1007/978-1-59745-520-6_19, 18368375.
15. Park MH, Jo SA, Jo I, Kim E, Eun SY, Han C, Park MK. No difference in stroke knowledge between Korean adherents to traditional and western medicine - the AGE study: an epidemiological study. BMC Public Health 2006, 6:153. 10.1186/1471-2458-6-153, 1550724, 16772038.
16. Jo SA, Kim EK, Park MH, Han C, Park HY, Jang Y, Song BJ, Jo I. Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin Chim Acta 2007, 382(1-2):43-47. 10.1016/j.cca.2007.03.016, 17459359.
17. Frances A, Mack AH, Ross R, First MB. The DSM-IV Classification and Psychopharmacology. 2000,
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):939-944.
19. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001, 58(12):1985-1992. 10.1001/archneur.58.12.1985, 11735772.
20. Lee KS, Chung JH, Choi TK, Suh SY, Oh BH, Hong CH. Peripheral cytokines and chemokines in Alzheimer's disease. Dement Geriatr Cogn Disord 2009, 28(4):281-287. 10.1159/000245156, 19828948.
21. Xia M, Qin S, McNamara M, Mackay C, Hyman BT. Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 1997, 150(4):1267-1274. 1858175, 9094983.
22. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 2008, 129(4):526-529. 10.1309/W01Y0B808EMEH12L, 2688655, 18343778.
23. Zuliani G, Guerra G, Ranzini M, Rossi L, Munari MR, Zurlo A, Blè A, Volpato S, Atti AR, Fellin R. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia. J Geriatr Psychiatry 2007, 22(4):305-311.
24. Sekine I, Yamamoto N, Nishio K, Saijo N. Emerging ethnic differences in lung cancer therapy. British Journal of Cancer 2008, 99:1757-1762. 10.1038/sj.bjc.6604721, 2600690, 18985035.
25. Simen BB, Duman CH, Simen AA, Duman RS. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006, 59(9):775-785. 10.1016/j.biopsych.2005.10.013, 16458261.
26. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhøj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999, 54(7):M357-364. 10.1093/gerona/54.7.M357, 10462168.
27. Hasegawa Y, Sawada M, Ozaki N, Inagaki T, Suzumura A. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology 2000, 46(4):185-188. 10.1159/000022157, 10859456.
28. Pickering M, Cumiskey D, O'Connor JJ. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 2005, 90(5):663-670. 10.1113/expphysiol.2005.030734, 15944202.
29. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M. Control of synaptic strength by glial TNFalpha. Science 2002, 295(5563):2282-2285. 10.1126/science.1067859, 11910117.
30. Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005, 25(12):3219-3228. 10.1523/JNEUROSCI.4486-04.2005, 15788779.
31. Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Bresolin N, Scarpini E. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. 2006, 27(12):1763-1768.
32. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P. Dutch-Italian Alzheimer Research Group. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol 2003, 53(4):547-548. 10.1002/ana.10531, 12666129.
33. Angelopoulos P, Agouridaki H, Vaiopoulos H, Siskou E, Doutsou K, Costa V, Baloyiannis SI. Cytokines in Alzheimer's disease and vascular dementia. Int J Neurosci 2008, 118(12):1659-1672. 10.1080/00207450701392068, 18937113.
34. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW. Interleukin-10 in the brain. Crit Rev Immunol 2001, 21(5):427-449.
35. Teunissen CE, de Vente J, Steinbusch HW, De Bruijn C. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol Aging 2002, 23(4):485-508. 10.1016/S0197-4580(01)00328-1, 12009495.
36. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010, 6(3):131-144. 10.1038/nrneurol.2010.4, 20157306.
37. Sun YX, Minthon L, Wallmark A, Warkentin S, Blennow K, Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2003, 16(3):136-144. 10.1159/000071001, 12826739.
38. De Luigi A, Pizzimenti S, Quadri P, Lucca U, Tettamanti M, Fragiacomo C, De Simoni MG. Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia. Neurobiol Dis 2002, 11(2):308-314. 10.1006/nbdi.2002.0556, 12505423.